Agenus Stock Analysis

AGEN -  USA Stock  

USD 2.69  0.01  0.37%

The big decline in price over the last few months for Agenus Inc could raise concerns from institutional investors as the firm it trading at a share price of 2.69 on 5,505,264 in volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Agenus Inc or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.0. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Agenus partners.
Please continue to Trending Equities.

Agenus Stock Analysis 

 
Refresh
The Agenus stock analysis report makes it easy to digest most publicly released information about Agenus and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Agenus Stock analysis module also helps to analyze the Agenus price relationship with some important fundamental indicators such as market cap and management efficiency.

Agenus Stock Analysis Notes

About 48.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 156.11. Agenus Inc next dividend is scheduled to be issued on the 29th of October 2010. The entity had 1:6 split on the 3rd of October 2011. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 359 people. For more info on Agenus Inc please contact Garo Armen at 781 674-4400 or go to www.agenusbio.com.

Agenus Quarterly Cost of Revenue

817,000Share

Agenus Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Agenus' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Agenus Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Agenus Inc generated a negative expected return over the last 90 days
Agenus Inc has high historical volatility and very poor performance
Agenus Inc has a very high chance of going through financial distress in the upcoming years
Agenus Inc currently holds about 261.53 M in cash with (2.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.
Agenus Inc has a frail financial position based on the latest SEC disclosures
Latest headline from www.investorsobserver.com: How Does Agenus Inc Stock Rank on Wall Street Wednesday - InvestorsObserver

Agenus Inc Upcoming and Recent Events

Earnings reports are used by Agenus to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Agenus previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of March 2022
Next Earnings Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End21st of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Agenus SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Agenus prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Agenus investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Agenus Inc specific information freely available to individual and institutional investors to make a timely investment decision.
6th of January 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
9th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
28th of October 2021
Unclassified Corporate Event
View
22nd of October 2021
Financial Statements and Exhibits. Other Events
View
9th of August 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
26th of July 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
16th of June 2021
Submission of Matters to a Vote of Security Holders
View
18th of May 2021
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
View

Agenus Thematic Classifications

In addition to having Agenus stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters IdeaCancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

Agenus Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Agenus is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Agenus Inc backward and forwards among themselves. Agenus' institutional investor refers to the entity that pools money to purchase Agenus' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Minot Wealth Management LlcCommon Shares47.6 K153 K
Diversified Trust CoCommon Shares40.8 K131 K
Lynch AssociatesCommon Shares27.8 K89 K
Gradient Investments LlcCommon Shares21 K68 K
Cutler Group LpCommon Shares6.7 K21 K
Key Financial IncCommon SharesK10 K
Allworth Financial LpCommon Shares1751000
Cutler Group LpCall Options12.4 K1000
Cutler Group LpPut Options1.7 K0.0
Note, although Agenus' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Agenus Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 721.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Agenus's market, we take the total number of its shares issued and multiply it by Agenus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Agenus Profitablity

Agenus' profitability indicators refer to fundamental financial ratios that showcase Agenus' ability to generate income relative to its revenue or operating costs. If, let's say, Agenus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Agenus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Agenus' profitability requires more research than a typical breakdown of Agenus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 1.3 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 24.5 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.25.
Last ReportedProjected for 2022
Return on Investment(104.52) (112.77) 
Return on Average Assets(0.83) (0.89) 
Return on Average Equity 0.80  0.86 
Return on Invested Capital 3.34  3.60 
Return on Sales(1.56) (1.68) 

Management Efficiency

The entity has return on total asset (ROA) of 13.27 % which means that it generated profit of $13.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 0.67 %, meaning that it created $0.67 on every $100 dollars invested by stockholders. Agenus management efficiency ratios could be used to measure how well agenus inc manages its routine affairs as well as how well it operates its assets and liabilities. Agenus Return on Average Equity is quite stable at the moment as compared to the past year. The company's current value of Return on Average Equity is estimated at 0.86. Return on Invested Capital is expected to rise to 3.60 this year, although the value of Return on Investment will most likely fall to (112.77) . Agenus Assets Non Current are quite stable at the moment as compared to the past year. The company's current value of Assets Non Current is estimated at 124.99 Million. Total Assets Per Share is expected to rise to 1.46 this year, although the value of Total Assets will most likely fall to about 199.4 M.
Last ReportedProjected for 2022
Book Value per Share(1.06) (1.15) 
Enterprise Value over EBIT(4.60) (4.96) 
Enterprise Value over EBITDA(5.38) (5.81) 
Price to Book Value(3.41) (3.68) 
Tangible Assets Book Value per Share 0.93  0.98 
Enterprise Value606.4 M484.5 M
Tangible Asset Value204.9 M162.7 M

Technical Drivers

As of the 24th of January, Agenus shows the risk adjusted performance of (0.14), and Mean Deviation of 3.2. Agenus Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Agenus Inc, which can be compared to its rivals. Please confirm Agenus Inc jensen alpha, and the relationship between the coefficient of variation and potential upside to decide if Agenus Inc is priced correctly, providing market reflects its regular price of 2.69 per share. Please also double-check Agenus Inc total risk alpha, which is currently at (0.51) to validate the company can sustain itself at a future point.

Agenus Inc Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Agenus Inc price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator. View also all equity analysis or get more info about mesa adaptive moving average overlap studies indicator.

Agenus Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agenus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Agenus Predictive Daily Indicators

Agenus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Agenus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Agenus Forecast Models

Agenus time-series forecasting models is one of many Agenus' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Agenus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Agenus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Agenus stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Agenus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Agenus. By using and applying Agenus Stock analysis, traders can create a robust methodology for identifying Agenus entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(53.75) (57.99) 
EBITDA Margin(1.47) (1.58) 
Gross Margin 1.12  1.16 
Profit Margin(2.36) (2.55) 
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 359 people.

Current Agenus Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Agenus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Agenus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
10.0Strong Buy3Odds
Agenus Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Agenus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Agenus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Agenus Inc, talking to its executives and customers, or listening to Agenus conference calls.
Agenus Analyst Advice Details

Agenus Stock Analysis Indicators

Agenus Inc stock analysis indicators help investors evaluate how Agenus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Agenus shares will generate the highest return on investment. By understating and applying Agenus stock analysis, traders can identify Agenus position entry and exit signals to maximize returns.
Quick Ratio1.89
Fifty Two Week Low2.5000
Revenue Growth1,605.50%
Average Daily Volume Last 10 Day3.62M
Shares Short Prior Month17.27M
Average Daily Volume In Three Month4.45M
Shares Percent Shares Out9.59%
Gross Margins46.49%
Forward Price Earnings-2.96
Short Percent Of Float9.66%
Float Shares227.11M
Fifty Two Week High6.7900
Fifty Day Average3.3766
Enterprise Value To Ebitda6.87
Two Hundred Day Average4.4697
Enterprise Value To Revenue1.68
Please continue to Trending Equities. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Agenus Stock analysis

When running Agenus Inc price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Agenus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine Agenus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.